As the clock strikes the start of 2026 and we bid farewell to the old year, we extend our warmest New Year greetings to all colleagues in the global pharmaceutical industry, friends from domestic and overseas pharmaceutical enterprises, dedicated researchers, medical professionals, and every individual who contributes to the cause of human health! The past year has witnessed the pharmaceutical sector’s unwavering efforts and remarkable progress. Domestic and foreign pharmaceutical companies joined hands to tackle challenges head-on: breakthroughs in the R&D and manufacturing of cutting-edge APIs such as oligonucleotides and peptides have strengthened the industry’s technological foundation; the continuous expansion of innovative drug pipelines has brought new hope to patients with unmet medical needs; smooth global business development and cooperation have promoted the flow of technologies, products and resources across borders; and strict compliance with international regulatory standards has laid a solid foundation for the high-quality development of the industry. In 2026, the global pharmaceutical landscape is poised for new opportunities and challenges. As personalized medicine gains momentum, as digitalization and intelligence reshape R&D and production models, and as global health equity becomes a shared pursuit, we look forward to deeper collaboration between domestic and overseas pharmaceutical enterprises. Let us join forces to accelerate the translation of scientific discoveries into clinical applications, optimize supply chain resilience, and promote the accessibility of high-quality pharmaceuticals worldwide. May the year 2026 bring you good health, fruitful achievements and lasting partnerships! Let us walk hand in hand, keep our mission in mind, and work together to build a healthier and brighter future for all!
